BioSpace News Archive

OntadaTM, McKesson’s oncology and insights business, today announced a strategic agreement with Merck, known as MSD outside the United States and Canada, that will facilitate the development of real-world research excellence and innovation.

Adagene Inc. today reported financial results for the six months ended June 30, 2021, and provided corporate updates.

Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, announced that Sanjeev Luther, President and CEO, will present at the World Orphan Drug Congress taking place on August 25-27 at the Gaylord National Resort & Convention Center in Oxon Hill, Maryland.

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), today announced that candidates from its Family 3 compounds, comprised of long-acting psilocybin side-chain restricted analogs, have demonstrated extended duration of action and decreased effect size at the 5-HT2A receptor.

Ikonopedia announced today that it has added Banner Health, one of the largest non-profit health care systems in the country, as a customer and will implement its entire suite of structured breast imaging reporting and MQSA management tools.

Ionpath, Inc. today announced a new program for biopharmaceutical research organizations interested in piloting spatial phenotyping analyses of tissue samples leveraging the company’s Multiplexed Ion Beam Imaging (MIBI™) technology.

Semler Scientific, Inc. today announced that Chief Executive Officer Doug Murphy-Chutorian , M.D. and Chief Marketing Officer Dennis Rosenberg will participate in the investor conferences that are being held virtually in September.

Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive Vice President and Chief Business Innovation Officer.

Metagenomi today announced the addition of Willard H. Dere, M.D., to the company’s board of directors.

Virpax ® Pharmaceuticals, Inc. today announced that it has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide and seven research and development facilities throughout the U.S. and Europe.